Across TCGA pan-cancer cohorts, RN7SL14P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RN7SL14P data layer.
The strongest signal is observed in rectum adenocarcinoma (READ), where higher RN7SL14P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL14P expression acts as an unfavorable survival marker, although some lineages such as LUSC and SARC show a favorable association.
READ, UVM, and KIRP are the cancer types where RN7SL14P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.